ALAlphabet Inc.

Institutional investor · Portfolio as of Q1 2023

SEC EDGAR SourceSEC Filings

Top Holdings49 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

UIPATH INC

14.1M$247M13.7%$12.71+31.24%
2 qtrssince 2022-Q4
Unchanged
0

PRIME MEDICINE INC

13.3M$163.4M9.1%$18.58-33.91%
2 qtrssince 2022-Q4
Unchanged
0

CROWDSTRIKE HOLDINGS INC - A

1.2M$159.7M8.9%$117.59+12.02%
2 qtrssince 2022-Q4
Increased
93

OSCAR HEALTH INC - CLASS A

24M$157.2M8.7%$2.46+169.11%
2 qtrssince 2022-Q4
Unchanged
0
VERVVERVDelisted

VERVE THERAPEUTICS INC

10.5M$152.1M8.4%
2 qtrssince 2022-Q4
Unchanged
0

DEXCOM INC

1.3M$145.2M8.1%$113.24+1.02%
2 qtrssince 2022-Q4
Unchanged
0

PLANET LABS PBC

31.9M$125.5M7.0%$4.35-17.93%
2 qtrssince 2022-Q4
Unchanged
0
EQRXEQRXDelisted

EQRx Inc.

47.7M$92.5M5.1%
2 qtrssince 2022-Q4
Unchanged
0

SNOWFLAKE INC-CLASS A

535,604$82.6M4.6%$143.54-1.00%
2 qtrssince 2022-Q4
Unchanged
0

DUOLINGO INC

523,824$74.7M4.1%$71.13+82.99%
2 qtrssince 2022-Q4
Decreased
0

GITLAB INC

1.9M$66.3M3.7%$41.33-20.13%
2 qtrssince 2022-Q4
Increased
76

FRESHWORKS INC

4M$62M3.4%$14.71+0.20%
2 qtrssince 2022-Q4
Unchanged
0

ROBINHOOD MARKETS INC - A

4.9M$47.9M2.7%$8.14+16.22%
2 qtrssince 2022-Q4
Unchanged
0

LYFT INC-A

3.7M$34.3M1.9%$11.02-17.42%
2 qtrssince 2022-Q4
Decreased
0

RELAY THERAPEUTICS INC

1.6M$25.8M1.4%$14.94+6.49%
2 qtrssince 2022-Q4
Unchanged
0
DMDMDelisted

Desktop Metal Inc.

11M$25.4M1.4%
BHILBHILDelisted

Benson Hill Inc.

15.4M$17.7M1.0%
2 qtrssince 2022-Q4
Unchanged
0
MEMEDelisted

23andMe Holding Co.

6.7M$15.4M0.9%
2 qtrssince 2022-Q4
Unchanged
0

LYELL IMMUNOPHARMA INC

5.9M$13.8M0.8%

ILLUMINA INC

53,470$12.4M0.7%$196.69+11.40%
2 qtrssince 2022-Q4
Unchanged
0
$1.8B
AUM
49
Positions
Q1 2023
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'23
New0%Increased63%Decreased31%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 quarters
<1Q2%1-4Q92%1-2Y0%2Y+6%

Alphabet Inc. manages $1.8B across 49 positions as of Q1 2023. Top holdings: PATH (13.7%), PRME (9.1%), CRWD (8.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q1 2023 Summary

Added 1 new position, exited 3, increased 3, trimmed 4. Top move: CRWD (INCREASED, conviction 93). Portfolio: $1.8B across 49 positions.

Top holdings by portfolio weight

Total AUM$2B
PATH13.70%
PRME9.06%
CRWD8.86%
OSCR8.72%
VERV8.43%
DXCM8.05%
PL6.96%
EQRX5.13%
SNOW4.58%
DUOL4.14%
Other3.68%

Portfolio allocation by GICS sector

Sectors5
Technology40.35%
Healthcare32.70%
Unknown17.30%
Industrials6.97%
Financial Services2.68%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used